Literature DB >> 22773349

Operative considerations in pediatric retroperitoneal teratomas--a review.

Vinci S Jones1, Cartland R Burns.   

Abstract

BACKGROUND: Retroperitoneal teratomas account for 5% of teratomas and occur predominantly in infants. The resection of these tumors has been variously reported as easy or difficult. This report presents a series of retroperitoneal teratomas and reviews the literature focusing on the relevant operative considerations in this tumor.
METHODS: A retrospective chart review from 1996 to 2011 identified five children with retroperitoneal teratomas. Clinical features, radiologic findings, operative details, and outcome were recorded. The literature was reviewed to identify operative complications for these tumors.
RESULTS: Out of the five patients, four were infants. The tumor was characterized by dense adhesions in all patients, and resection was complicated by gastric and common bile duct injury. Hiatal hernia repair was required in one and spillage was seen in two patients. One patient had a staged resection after birth with colostomy, vesicostomy, and eventual death on day 12 of life. Inferior vena cava (IVC) ligation was required in one. A total of four patients were well on long-term follow-up. Review of the literature revealed that computed tomography scan while being sufficient for diagnosing a retroperitoneal teratoma is often inadequate in delineating the vascular anatomy, which is usually distorted. The IVC and the mesenteric vessels may be inseparable and require ligation. Renal vessel injury is possible, leading onto ischemia and hypertension. The tumor may be intimately adherent to the viscera in the abdomen, making resection complicated. Adequate resection is possible and necessary for cure, but not always possible with clear resection margins. Late complications include recurrence, adhesions, and hypertension. The perioperative mortality is 0 to 8% and the complication rate is 50 to 100%.
CONCLUSION: Surgical resection of retroperitoneal teratomas, while being the mainstay of treatment is challenging in view of its size, adhesions, and vascular distortion. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773349     DOI: 10.1055/s-0032-1313338

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Surgical intervention and perioperative risk factors of retroperitoneal teratomas in children: a single institution experience.

Authors:  Shigehisa Fumino; Junnosuke Maniwa; Yuki Takeuchi; Kohei Sakai; Mayumi Higashi; Shigeyoshi Aoi; Taizo Furukawa; Osamu Kimura; Tatsuro Tajiri
Journal:  Pediatr Surg Int       Date:  2016-07-30       Impact factor: 1.827

2.  Mature Teratoma at Left Lumbar Region in an Infant: A Case Report.

Authors:  Rajendra Kumar Ghritlaharey
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Retroperitoneal teratoma misdiagnosed as a gastric stromal tumor: A case report.

Authors:  Liming Gan; Qiulin Huang
Journal:  Mol Clin Oncol       Date:  2020-03-19

4.  Case Reports: Management Challenges in Pediatric Germ Cell Tumors.

Authors:  Sophie Carr; Arash Safavi; Erik D Skarsgard
Journal:  Front Pediatr       Date:  2021-04-15       Impact factor: 3.418

5.  Retroperitoneal teratomas in children: a single institution experience.

Authors:  Takafumi Kawano; Koshiro Sugita; Chihiro Kedoin; Ayaka Nagano; Mayu Matsui; Masakazu Murakami; Masato Kawano; Keisuke Yano; Shun Onishi; Toshio Harumatsu; Koji Yamada; Waka Yamada; Ryuta Masuya; Makoto Matsukubo; Mitsuru Muto; Seiro Machigashira; Kazuhiko Nakame; Motoi Mukai; Tatsuru Kaji; Satoshi Ieiri
Journal:  Surg Today       Date:  2021-06-19       Impact factor: 2.549

6.  Surgical treatment of a retroperitoneal benign tumor surrounding important blood vessels by fractionated resection: A case report and review of the literature.

Authors:  Zhili Wan; Tiansheng Yin; Hongwei Chen; Dewei Li
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.